- Home
- Automated
- List of product information
- RESINSODIO POWDER 4.95 G/5 G [SIN09521P]
RESINSODIO POWDER 4.95 G/5 G [SIN09521P]
Active ingredients: RESINSODIO POWDER 4.95 G/5 G
Product Info
RESINSODIO POWDER 4.95 G/5 G
[SIN09521P]
Product information
Active Ingredient and Strength | SODIUM POLYSTYRENE SULPHONATE - 4.95 G/5 G |
Dosage Form | POWDER, FOR SUSPENSION |
Manufacturer and Country | LABORATORIOS RUBIO SA - SPAIN |
Registration Number | SIN09521P |
Licence Holder | ZYFAS MEDICAL CO |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | V03AE01 |
INDICATIONS
Treatment of hyperkalaemia.
Dosage and Administration
Administer sodium polystyrene sulfonate at least 3 hours before or 3 hours after other oral medications. Patients with gastroparesis may require a 6 hour separation.
POSOLOGY
Oral administration. The average daily adult dose of the resin is 15g to 60g (approximately 3 level teaspoons one to four times daily) as a suspension in water or syrup. A suggested dose for children is up to 1g per Kg body-weight by mouth in divided doses, reduced to 500 mg per Kg. Suspension of this drug should be freshly prepared and not stored beyond 24 hours. When oral administration is difficult, Resinsodio may be administered rectally as an enema at a dose of 30-50 g in 100 ml of an aqueous vehicle (such as sorbitol solution) every 6 hours in adults, and at a dose similar to those suggested by mouth in children and neonates. The enema should be retained as long as possible (6–9 hours) and followed by a cleansing enema.
CONTRAINDICATIONS
Resinsodio is contraindicated in patients with hypokalaemia, in patients with obstructive bowel disease, or those patients who are hypersensitive to it.
